Cargando…

Initial evaluation of [(18)F]-FACBC for PET imaging of multiple myeloma

RATIONALE: Multiple myeloma (MM) cells synthesize large amounts of paraproteins, making radiolabeled amino acids promising candidates for PET imaging of MM patients. METHODS: We compare tumor uptake of the two amino acid analogs [(18)F]-fluoroethyltyrosine and [(18)F]-FACBC in a MM xenograft model a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morath, Volker, Heider, Michael, Mittelhäuser, Markus, Rolbieski, Hannes, Stroh, Jacob, Calais, Jérémie, Eiber, Matthias, Bassermann, Florian, Weber, Wolfgang A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804025/ https://www.ncbi.nlm.nih.gov/pubmed/35099620 http://dx.doi.org/10.1186/s13550-022-00876-0

Ejemplares similares

(18)F-Fluciclovine ((18)F-FACBC) PET imaging of recurrent brain tumors
por: Michaud, Laure, et al.
Publicado: (2019)

Diagnostic Value of (18)F-FACBC PET/MRI in Brain Metastases
por: Øen, Silje Kjærnes, et al.
Publicado: (2022)

(18)F-FACBC PET/MRI in the evaluation of human brain metastases: a case report
por: Johannessen, Knut, et al.
Publicado: (2021)

Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
por: Movahedi, Parisa, et al.
Publicado: (2020)

Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
por: Bin, Xu, et al.
Publicado: (2020)

(18)F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Laudicella, Riccardo, et al.
Publicado: (2019)

Assessment of Amino Acid/Drug Transporters for Renal Transport of [(18)F]Fluciclovine (anti-[(18)F]FACBC) in Vitro
por: Ono, Masahiro, et al.
Publicado: (2016)

Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT Imaging in Prostate Cancer Patients
por: Kairemo, Kalevi, et al.
Publicado: (2014)

Detection Rate and Clinical Impact of PET/CT with (18)F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study
por: Filippi, Luca, et al.
Publicado: (2022)

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
por: Heider, Michael, et al.
Publicado: (2021)

Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET/CT: a bi-centric analysis
por: Gafita, Andrei, et al.
Publicado: (2019)

Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on (18)F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer
por: Notohamiprodjo, Susan, et al.
Publicado: (2022)

Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET/CT in cancer patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
por: Stroh, Jacob, et al.
Publicado: (2022)

[(18)F]Fludarabine-PET in a murine model of multiple myeloma
por: Hovhannisyan, Narinée, et al.
Publicado: (2017)

A rare case of polyostotic fibrous dysplasia detected on (18)F-rhPSMA-7 PET/CT
por: Wang, Hui, et al.
Publicado: (2020)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

PET/CT F18-FDG with soft tissue plasmacytomas in multiple myeloma
por: Martí, Alejandro, et al.
Publicado: (2021)

Pitfalls in PSMA imaging: [(18)F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
por: Feuerecker, B., et al.
Publicado: (2021)

Multiparametric 18F–FDG PET/MR follow-up in a patient with autoimmune pancreatitis
por: Rauscher, Isabel, et al.
Publicado: (2017)

(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma
por: Regelink, J. C., et al.
Publicado: (2016)

Polymicrobial Pyomyositis in a Patient with Suspected Myeloma on (18)F-FDG PET-CT
por: Kalra, Simran, et al.
Publicado: (2022)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

A First Report on [(18)F]FPRGD(2) PET/CT Imaging in Multiple Myeloma
por: Withofs, Nadia, et al.
Publicado: (2017)

Non-prostate uptake on (18)F-PSMA-1007 PET/CT: a case of myeloma
por: Veerasuri, Sowmya, et al.
Publicado: (2020)

Case of non‐secretory multiple myeloma eventually diagnosed by (18)F‐FDG PET/CT
por: Haratake, Daisuke, et al.
Publicado: (2022)

Double-strand breaks in lymphocyte DNA of humans exposed to [(18)F]fluorodeoxyglucose and the static magnetic field in PET/MRI
por: Brix, Gunnar, et al.
Publicado: (2020)

[(18)F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
por: Polverari, Giulia, et al.
Publicado: (2020)

Preclinical biodistribution and dosimetry and human biodistribution comparing (18)F-rhPSMA-7 and single isomer (18)F-rhPSMA-7.3
por: Knorr, Karina, et al.
Publicado: (2022)

Detection Efficacy of (18)F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
por: Giesel, Frederik L., et al.
Publicado: (2019)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
por: Gafita, Andrei, et al.
Publicado: (2022)

(18)F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
por: Crompton, Joseph G., et al.
Publicado: (2022)

Quantitative, Dynamic (18)F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Can (18)F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?
por: Sachpekidis, Christos, et al.
Publicado: (2020)

(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
por: Morales-Lozano, Maria I., et al.
Publicado: (2022)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined (18)F-FDG and (18)F-FLT PET/CT imaging
por: Sachpekidis, C., et al.
Publicado: (2018)

(18)F-fluoro-ethyl-tyrosine ((18)F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study
por: Czyż, Jarosław, et al.
Publicado: (2019)

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
por: Calais, Jeremie, et al.
Publicado: (2021)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fo06hv3a5roam7okmeg002dddl